Screening

18 drugs in development·13 companies·2 clinical trials

Drug Pipeline by Phase

Approved(3)

Drug	Company
Alinity® family	ABBOTT LABORATORIES (ABT)
autoimmune analyzer	Quest Diagnostics Incorporated (DGX)
baclofen	MAIA Biotechnology, Inc. (MAIA)

Preclinical(8)

Drug	Company
a+lcguard	Advanced Biomed Inc. (ADVB)
Biopharma Services - Antibody Discovery	Twist Bioscience Corp (TWST)
cardiomap	Odyssey Health, Inc. (ODYY)
matloc	MARIZYME, INC. (MRZM)
matloc 1	MARIZYME, INC. (MRZM)
mosaiq	Quotient Ltd (QTNT)
nu.q	HESKA CORP (HSKA)
nu.q cancer	VOLITIONRX LTD (VNRX)

Unknown(7)

Drug	Company
Asuragen-branded products	BIO-TECHNE Corp (TECH)
Epi+Gen CHD™	Cardio Diagnostics Holdings Inc. (CDIO)
Foresight	MYRIAD GENETICS INC (MYGN)
Foresight Universal Plus	MYRIAD GENETICS INC (MYGN)
Precision DNA libraries	Twist Bioscience Corp (TWST)
Prequel	MYRIAD GENETICS INC (MYGN)
Prequel Prenatal Screen	MYRIAD GENETICS INC (MYGN)

BioSniper tracks 18 drugs in development for Screening across 13 companies.

There are 2 clinical trials targeting Screening tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.